Page 11 - Automated Cell News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Automated cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Automated Cell Today - Breaking & Trending Today

LUNA-FX7™ Automated Cell Counter

2 February 2021
Introducing the LUNA-FX7™ - the newest member of the award-winning LUNA™ Cell Counter family. The LUNA-FX7™ and the most powerful cell counter to date, with unmatched cell counting accuracy, new 1, 3 and 8-chamber slide options, state of the art optics, dual fluorescent and brightfield detection, precision autofocus, and 21 CFR PART 11 compliance. The LUNA-FX™ has built-in quality control features and precision validation slides for monitoring QC and production to help improve the efficiency and security of your lab s workflow.
Download 10,000+ ....

Application Note , Automated Cell , Cell Counter , விண்ணப்பம் குறிப்பு , தானியங்கி செல் , செல் எதிர் ,

Hemostemix Inc.: Hemostemix Announces HS 12 - 01 Clinical Trial Completion of Subjects' Follow-Up Visits at the End of March and Warrants Extended and Repriced

Hemostemix Inc.: Hemostemix Announces HS 12 - 01 Clinical Trial Completion of Subjects Follow-Up Visits at the End of March and Warrants Extended and Repriced
Hemostemix or the
Company ) is pleased to announce that all follow-up visits of the subjects enrolled in the HS 12 -01 clinical trial will be completed by March 31, 2021. A total 65 subjects who were enrolled in the trial, randomized 2:1 to receive ACP-01 or a placebo, will have completed the last follow-up appointments by March 31, 2021. The Company will provide additional information once trial data has been analyzed.
Warrant Amendments
The Company announces it is applying to the TSX Venture Exchange ( TSX-V ) for approval to amend the exercise price and expiration date of outstanding warrants (the ....

Thomas Smeenk , Kostenloser Wertpapierhandel , World Economic Forum Technology Pioneer Award , Hemostemix Inc , Regulation Service Provider , Alberta Newsfile Corp , Insiders Of The Company , Venture Exchange , Original Private Placements , Multilateral Instrument , Minority Shareholders , Special Transactions , Ischemic Cardiomyopathy , Dilated Cardiomyopathy , Stem Cell Treatment , Regulating Stem Cells , Vitro Techniques , Stem Cells , Neural Lineage , Automated Cell , Looking Information , உலகம் பொருளாதார மன்றம் தொழில்நுட்பம் முன்னோடி விருது , ஒழுங்குமுறை சேவை வழங்குநர் , உள் ஆஃப் தி நிறுவனம் , துணிகர பரிமாற்றம் , ஒரிஜிநல் ப்ரைவேட் வேலைவாய்ப்புகள் ,

Hemostemix Inc.: Hemostemix Announces Private Placement Update

Hemostemix Inc.: Hemostemix Announces Private Placement Update
Hemostemix or the
Company ) announces that it was granted price protection of its previously announced non-brokered private placement of units (
Units ) announced on December 18, 2020, for gross proceeds of up to $2,750,000 (the
Offering ). The Offering will consist of the issuance of an aggregate of up to 9,166,666 post rollback Units at a price of $0.30 per Unit. Each Unit consists of one post rollback common share in the capital of the Company (
Common Share ) and one post rollback common share purchase warrant (
Warrant ), with each full Warrant entitling the holder to acquire one Common Share at a price of $1.00 per Common Share for a period of 12 months from the closing of the Offering, subject to the accelerated expiry provision described below. ....

United States , Thomas Smeenk , Kostenloser Wertpapierhandel , Alberta Securities Commission Rule , Exchange On , Regulation Service Provider , World Economic Forum Technology Pioneer Award , Hemostemix Inc , Venture Exchange , Alberta Newsfile Corp , Company Common Share , Each Unit , Common Share , Multilateral Instrument , Minority Security Holders , Special Transactions , Existing Security Holders , Ischemic Cardiomyopathy , Dilated Cardiomyopathy , Stem Cell Treatment , Regulating Stem Cells , Vitro Techniques , Stem Cells , Neural Lineage , Automated Cell , ஒன்றுபட்டது மாநிலங்களில் ,

Hemostemix Inc.: Hemostemix Announces Corporate Update

Calgary, Alberta (Newsfile Corp. - December 23, 2020) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) ("Hemostemix" or the "Company") The Company is pleased to announce that the previously disclosed proposed ....

United States , Thomas Smeenk , Kostenloser Wertpapierhandel , World Economic Forum Technology Pioneer Award , Hemostemix Inc , Regulation Service Provider , Alberta Newsfile Corp , Venture Exchange , Annual General Meeting , Ischemic Cardiomyopathy , Dilated Cardiomyopathy , Stem Cell Treatment , Regulating Stem Cells , Vitro Techniques , Stem Cells , Neural Lineage , Automated Cell , ஒன்றுபட்டது மாநிலங்களில் , உலகம் பொருளாதார மன்றம் தொழில்நுட்பம் முன்னோடி விருது , ஒழுங்குமுறை சேவை வழங்குநர் , துணிகர பரிமாற்றம் , ஆண்டு ஜநரல் சந்தித்தல் , தண்டு செல் சிகிச்சை , விட்ரோ நுட்பங்கள் , தண்டு செல்கள் , நரம்பியல் பரம்பரை ,

Hemostemix Inc.: Hemostemix Announces Closing of Existing Private Placement and Announces a New Private Placement

Hemostemix Inc.: Hemostemix Announces Closing of Existing Private Placement and Announces a New Private Placement
Hemostemix or the
Units ) for gross proceeds of $1,272,117.04 (the
Offering ). The Offering consisted of the issuance of an aggregate of 127,211,704 Units at a price of $0.01 per Unit. Each Unit consists of one common share in the capital of the Company (
Common Share ) and one common share purchase warrant (
Warrant ), with each full Warrant entitling the holder to acquire one Common Share at a price of $0.05 per Common Share for a period of 12 months from the closing of the Offering, subject to the accelerated expiry provision described below. ....

United States , Thomas Smeenk , Kostenloser Wertpapierhandel , Alberta Securities Commission Rule , Regulation Service Provider , World Economic Forum Technology Pioneer Award , Hemostemix Inc , Venture Exchange Inc , Venture Exchange , Alberta Newsfile Corp , Company Common Share , Each Unit , Common Share , Multilateral Instrument , Minority Security Holders , Special Transactions , Each Warrant , Existing Security Holders , Ischemic Cardiomyopathy , Dilated Cardiomyopathy , Stem Cell Treatment , Regulating Stem Cells , Vitro Techniques , Stem Cells , Neural Lineage , Automated Cell ,